XARNA aims to deliver highly effective, safe, and globally-accessible mRNA vaccines by employing highly advanced mRNA-specific antigen design innovations.
Expertise
Led by globally acclaimed antiviral
researchers with proven drug
discovery success.
Innovation
Design mRNA specific
antigen construct.
Speed
Streamlined development enables
faster preclinical progress and
IND filing.
Opportunity
Addresses a massive unmet
need in global Hepatitis C
prevention.
XARNA Medicine utilizes Samyang’s Stability Enhanced Nano Shell (SENS™) drug delivery system and ST Pharm’s SmartCap™ technology for its mRNA vaccine pipelines. Both ST Pharm and Samyang Biopharm provide XARNA Medicine with complimentary access to these advanced mRNA-related technologies.
With decades of combined experience, our team brings a deep well of knowledge, skill, and proven success. We’ve embraced innovation and consistently delivered results that stand the test of time.